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Chapter 10 
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ABSTRACT 
The February 2010 release of the Draft Toxicological Review of Inorganic Arsenic 
by the U.S. Environmental Protection Agency provoked discussion of a potential 
significant downward revision of the arsenic cancer slope factor (CSF), which would be 
applicable to many oral exposure evaluations.  Given the extreme variability in soil 
cleanup guidelines that are in use throughout the United States and internationally for 
arsenic, it may be appropriate to more seriously consider bifurcating the manner in which 
arsenic is evaluated in environmental media.  In much the same fashion by which 
manganese and cadmium presently are evaluated from a risk perspective, arsenic may 
lend itself to similar evaluation from a drinking water exposure standpoint separately 
from a dietary or an environmental soil route of exposure.  This paper examines the basis 
for the current oral toxicological guidance with respect to specific exposure route and 
environmental medium of exposure, and addresses possible means for alternative toxicity 
guidance related to arsenic, based on differences in exposure through soil or the diet. 
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Arsenic is the perennial number one entry in the CERCLA Priority List of Hazardous 
Substances (ATSDR, 2007a), and is listed as a constituent of concern at more than 40% 
of NPL sites (ATSDR, 2007b).  Although the CERCLA list is not based solely on 
toxicity, and the NPL occurrence is based primarily on exceedance of often artificially 
low cleanup guidelines, the perception is such that arsenic, no matter the medium, 
accessibility, or concentration, is a serious human health concern.  As with most 
meaningful health questions that are posed, the true answer to the question of whether 
arsenic is a concern is “It depends”.  It depends on the arsenic form (inorganic, organic).  
It depends on the exposure medium (soil, food, air, water).  It depends on the intake route 
(oral, dermal, inhalation).  It depends on the exposure magnitude (concentration, 
duration).  Any one of these factors, or more likely, a combination of them all, 
determines whether arsenic can exert its ability to cause toxic effects. 
In the case of arsenic toxicity, particularly from exposure to soils, health-based 
screening levels and some cleanup guidelines are derived using conclusions largely based 
upon long term, high concentration drinking water studies, resulting in sub part per 
million protective soil targets.  Human exposures to soil arsenic at concentrations far in 
excess of these health-based screening levels occur frequently in all parts of the U.S. and 
worldwide.  However, reports conclusively connecting exposures to arsenic in soil with 
adverse health effects are not readily found in the toxicological literature. 
2. NATURAL OCCURENCE 
Many, if not a substantial majority of, areas in the U.S. contain soils that have 
measurable levels of arsenic.  Often, these detectable levels are referred to as “elevated.”  
Of course, elevated is the operative word defining the discussion.  Depending on the 
screening level that is considered, even naturally occurring background concentrations of 
arsenic in surface soil may be viewed as “elevated.”  By way of example, a 2009 study by 
Vosnakis, et al. evaluated more than 1,600 samples from 189 sites in seven states in the 
northeastern U.S. (KY, MD, NY, OH, PA, VA, WV).  The authors found that, following 
data validation and site screening, the retained arsenic in soil results ranged from 1.1 
mg/kg to 89 mg/kg (Vosnakis, et al., 2009; see Table 1).  When compared with each 
state’s soil screening level for arsenic, the reported background concentrations were from 
2x to 40x greater than the respective screening levels, and the highest background level 
was approximately 60x the lowest screening level. 
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Table 1.  Arsenic Background vs Soil Screening Levels for 7 States 
    95th Percentile Risk Based 
  Frequency Surface Soil As Screening Level 
State  of Detection (mg/kg) (mg/kg) 
Kentucky 57 of 57 15.6 0.39 
Maryland 28 of 32 10.1 0.39 
New York 42 of 50 22.8 13 
Ohio 94 of 143 21.7 6.8 
Pennsylvania 219 of 220 23.7 12 
Virginia 91 of 98 13.6 0.39 
W Virginia 314 of 316 15 8.64 
Each of these states allows for some consideration of background in their cleanup 
guidance, and a few incorporate background directly into the screening levels.  However, 
the fact remains that large areas of soil in the U.S. exceed health-based screening levels 
for arsenic. 
3. HEALTH EFFECTS 
Given the intrinsic toxicity of arsenic, the very low soil screening levels theoretically 
required to protect human health, and the presence in most soil of arsenic far exceeding 
health-based guidelines, where are all of the reports of arsenic-related illness, disease and 
death?  Going briefly back to the Vosnakis, et al. (2009) study of elevated background 
arsenic, we can look at selected state soil concentrations and compare those with reported 
cancer incidences.  As shown on Table 2, even though statewide soil arsenic 
concentrations are twice or three times the national average, and up to 60-times greater 
than the lowest RBSL, cancer incidence rates for bladder, liver and skin cancer are not 
significantly different from national rates. 
Clearly, establishing a causal link between any factor and the development of cancer 
is a highly complex undertaking, but at the theoretical doses (and the associated grossly 
elevated risk levels) suggested by the above soil concentrations, the logical conclusion 
would be that rates broadly elevated beyond screening levels would be associated with 
noticeably elevated cancer incidences.  In further attempts to support that hypothesis, 
Hinwood et al. (1999), in an Australian study of residential areas having soil arsenic 
concentrations greater than 100 mg/kg, did not show a statistically significant increase in 
relevant cancer incidences. 
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Table 2.  Selected State Cancer Incidence Rates (NCI, 2010) 
(cases per 100,000 population per year, 2004-2008) 
  Bladder Liver Skin 
  Cancer Cancer Cancer 
Location (background As) Incidence Incidence Incidence 
U.S. (7.2 mg/kg; ATSDR, 2007b) 21.2 6.2 18.8 
Kentucky (15.6 mg/kg) 22.6 5.1 22.3 
New York (22.8 mg/kg) 23.9 7.6 15.8 
Pennsylvania (23.7 mg/kg) 25.2 6.1 17.7 
The above observation is consistent with the opinion of multiple authors who have 
proposed a sublinear or threshold basis for arsenic carcinogenicity, irrespective of 
medium of exposure (Rudel, et al., 1996; ERG, 1997; ATSDR, 2007b).   
Consistent with the lack of evidence supporting cancers resulting from common soil 
arsenic exposures, no articles or studies were found citing systemic effects following 
human exposure to arsenic in soil under normal circumstances.  In a German study of the 
potential transfer of arsenic from the environment to humans, it was observed that hair 
and urine arsenic levels actually were lower in the study area of elevated arsenic than in 
the reference area of low arsenic concentrations (Gebel, et al, 1998).  Soil levels in the 
former mining region ranged from 2 to 605 mg/kg, but drinking water had low arsenic, 
and no occupational exposure was noted.  Although a slight increase in hair and urine 
levels was associated with increasing soil levels, the most significant factor contributing 
to the observed levels was seafood consumption. 
4. WHY THE DISCONNECT? 
So, it is clear that arsenic occurs naturally and frequently in soils at levels much 
greater than health-based regulatory guidelines.  There also is some evidence that cancer 
incidence is not elevated in areas of elevated soil arsenic, and there is a notable lack of 
evidence that elevated soil arsenic results in adverse systemic effects. 
Many authors have reported on the various aspects that are involved in arsenic 
occurrence in soil, exposure, toxicokinetics, and toxicity, but very little consensus has 
developed at this point.  Over the past several years, even the recognized certainty that 
arsenic methylation in the human body is a key detoxification step has been shown to be 
less than reliable (Thomas, et al., 2001; 2007; Hughes, et al., 2011; Steinmaus, et al., 
2000).  Other key areas of debate include whether arsenic is indeed a linear, nonthreshold 
carcinogen, or, as offered by many authors, a threshold carcinogen, or at the least a 
sublinear carcinogen (ERG, 1997; Abernathy, et al., 1996; Carlson-Lynch, et al., 1994; 
Lamm, et al., 2004).  Separate from further refinement of the fundamental question of 
carcinogenicity from drinking water exposure, this paper pursues a solution to the 
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disparity between the observed drinking water toxicity and the lack of reported health 
effects from exposure to elevated soil arsenic. 
The list of possible explanations for the disconnect is long, and includes at least the 
following: 
• arsenic form (inorganic, organic); 
• exposure medium (soil, food, air, water); 
• methylation and other toxicokinetic processes (absorption, detoxification or 
activation); 
• intake route (oral, dermal, inhalation); and, 
• exposure magnitude (concentration, duration). 
Any one of these factors, or more likely, a combination of them all, determines 
whether arsenic can exert its potential to cause toxic effects. 
5. POSSIBLE SOLUTIONS 
In order to resolve the inconsistency observed between the adverse effects from 
exposure to arsenic in drinking water and the lack of actual or reported harm from 
elevated soil arsenic, three of the most readily quantifiable influences were evaluated: 1) 
relative bioavailability, to address intake route and exposure medium; 2) analogy to 
cadmium and manganese, to address absorption and exposure medium; and, 3) inorganic 
versus organic form of exposure. 
5.1 Relative bioavailability adjustment 
As noted earlier, a few state environmental agencies (e.g., Florida Department of 
Environmental Protection) explicitly acknowledge the oft-reported reduced relative oral 
bioavailability of arsenic in soil within their cleanup guidelines development process 
(FDEP, 2005).  The most frequently reported range for relative bioavailability adjustment 
(RBA) is on the order of 20 to 60 percent (ATSDR, 2007b; Roberts, et al., 2002; 
Bradham, et al., 2011; Freeman, et al., 1993; 1995), while ranges from 5 to 75 percent are 
not unheard of.  Thus, taking 30 percent as the midrange estimate, and 5 and 75 percent 
as the low and high estimates, respectively, Table 3 presents plausible risk based 
screening levels (RBSLs) for arsenic that would be calculated using procedures 
consistent with development of the USEPA regional screening levels (RSLs; USEPA, 
2011a). 
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Table 3.  Arsenic RBSLs based on estimated RBA 
Reported Default EPA RBSL RBA-Based RBSL 
RBA Estimates mg/kg mg/kg 
Default (100%) 0.39 0.39 
Upper (75%) 0.39 0.52 
Mid (30%) 0.39 1.3 
Lower (5%) 0.39 7.8 
As shown on Table 3, the midrange RBA estimate results in a possible RBSL of 1.3 
mg/kg.  While this value is scientifically defensible, health-based, and it provides 
considerable relief from default guidelines, it does not remotely approach naturally 
occurring arsenic levels in most soils in the U.S.  Thus, adjustments for RBA are 
appropriate, based on a multitude of studies, but RBA adjustment is likely only a piece of 
the puzzle. 
5.2 Exposure medium/route adjustment 
In the case of cadmium and, to a lesser extent, manganese, the route of exposure 
dictates the applicable toxicological guidance that is recommended for use in risk 
assessment and cleanup activities.  The oral RfD for cadmium when the exposure 
medium is water is 5E-4 mg/kg•day, and the oral RfD for cadmium in food is 1E-3 
mg/kg•day (IRIS; USEPA, 2011b), or twice that for water.  The IRIS profile for cadmium 
reports that the difference in RfD values is based on observed differences in absorption 
(i.e., 2.5% absorption of Cd from food or 5% from water; USEPA, 2011b).  Specifically, 
it states “Since the fraction of ingested Cd that is absorbed appears to vary with the 
source (e.g., food vs. drinking water), it is necessary to allow for this difference in 
absorption when using the toxicokinetic model to determine an RfD.”  For cadmium, the 
differences in toxicological guidance typically are reflected in differential media 
screening levels through use of the water RfD when calculating the tapwater level and 
through use of the food RfD when calculating the soil level (FDEP, 2005; USEPA, 
2011a). 
With respect to human absorption of arsenic, very little consensus is available, but 
there does appear to be a reduced absorption rate in animal studies when comparing 
insoluble, bound arsenic forms (i.e., those most often found in soil) with soluble, 
unbound arsenic forms (i.e., those most often found in drinking water; ATSDR, 2007b; 
NRC, 1999).  Freeman et al. (1993) reported that, in rabbits, approximately 80% of the 
arsenic from an ingested soil bolus (primarily smelting soil in the form of sulfides) was 
eliminated (i.e., approximately 20% absorption).  In contrast, 50% of a soluble oral dose 
and 10% of an injected dose were eliminated (i.e., 50% and 90% absorption, 
respectively).  Thus, arsenic absorption from soil may range from 30-70% less than 
absorption from more soluble forms.  This conclusion is consistent with results from 
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Roberts et al. (2002) who reported that between 60% and 80% of an ingested arsenic dose 
in soil was eliminated by Cebus apella monkeys, suggesting absorption of 20% to 40%. 
Although much work is needed to refine knowledge regarding human absorption 
differences based on medium of exposure, the likely impact would be in the same general 
magnitude as that presented for adjustments based on relative bioavailability (e.g., 1.5 to 
20 fold; see Table 3).   
5.3 Form of arsenic adjustment 
One promising potential solution to the presence/significance conundrum may lie in 
being able decisively to identify the form of arsenic, inorganic or organic, to which an 
individual is exposed.  Determining which form is present in the soil, and, more 
importantly, identifying which form ultimately is present in the body following human 
exposure, is a subject of considerable debate.  However, as presented by ATSDR 
(2007b), distinct chronic human oral minimal risk levels (MRLs) are available for 
inorganic and organic forms of arsenic, thus providing a potential mechanism for 
development of screening levels, if consensus on typical exposure forms in specific 
media can be reached. 
The inorganic MRL is 3E-4 mg/kg•day and that value was derived from a human 
drinking water study.  For the organic arsenic compounds monomethylarsonic acid 
(MMA) and dimethylarsinic acid (DMA), the chronic human oral MRLs are 1E-2 
mg/kg•day and 2E-2 mg/kg•day, respectively (ATSDR, 2007b), and both of these values 
are based on feeding studies in mice.  The MRL development process is conceptually 
similar to that which is used to produce Reference Doses, including the application of 
uncertainty and modifying factors.  Thus, analogous to the development of USEPA 
default RSLs, risk based screening levels (RBSLs) may be developed for arsenic in soil 
using the MRLs for inorganic arsenic and organic arsenic compounds.  As shown on 
Table 4, the proposed RBSLs for organic arsenic in soil range from nearly 30 times 
greater to more than 50 times greater than the RBSL for inorganic arsenic in soil. 
Table 4.  Arsenic RBSLs based on form-specific toxicological guidance 
Chronic Default MRL-Based 
Oral MRL EPA RSL RBSL 
As Form mg/kg•day mg/kg mg/kg 
Inorganic 0.0003 0.39 22 
Organic (MMA) 0.01 NA ~600 
Organic (DMA) 0.02 NA ~1,200 
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6. DISCUSSION 
Significant monetary and human resources are expended on the characterization and 
mitigation of arsenic in soil, based primarily on the fundamental assumption that its 
potential toxicity following soil exposure is consistent with its potential toxicity 
following drinking water exposure.  No conclusive reports were found to support that 
position, and an increasing body of evidence is available to undermine the conclusion.  
While the exact mechanisms and processes that result in the disparity remain unclear, it is 
time to begin refining an approach to the multiple potential solutions to the problem.  As 
presented in this paper, the most promising and straightforward solutions lie in 
adjustments to the numerical toxicological guidance based on several factors including: 
1) relative bioavailability; 2) differences in absorption between the water and soil 
matrices; and/or, 3) differences in the toxicity between inorganic and organic forms of 
arsenic. 
Possible recommendations for future health investigations, as well as a few critical 
areas for continued toxicological study include the following: 
• inorganic vs organic determination whenever soil investigations take place; 
• refined toxicokinetics to conclusively identify methylation or other relevant 
processes and their importance; 
• inexpensive, rapid in vitro methods for site-specific determinations of relative 
bioavailability; and, 
• more conclusive determination of the mode of action for arsenic carcinogenicity. 
7. REFERENCES 
Abernathy, C.O., Chappell, W.R., Meek, M.E., Gibb, H., and Guo, H-R.  1996.  Is Ingested Inorganic 
Arsenic a “Threshold” Carcinogen?  Fund Appl Toxicol 29: 168-175. 
ATSDR (Agency for Toxic Substances and Disease Registry).  2007a.  2007 CERCLA Priority List of 
Hazardous Substances that will be the Subject of Toxicological Profiles and Support Document.  
December 2007. 
ATSDR (Agency for Toxic Substances and Disease Registry).  2007b.  Toxicological Profile for Arsenic.  
Update.  August 2007. 
Bradham, K.D., Scheckel, K.G., Nelson, C.M., Seales, P.E., Lee, G.E., Hughes, M.F., Miller, B.W., Yeow, 
A., Gilmore, T., Harper, S., and Thomas, D.J.  2011.  Relative Bioavailability and Bioaccessibility and 
Speciation of Arsenic in Contaminated Soils.  Environ Health Perspect.  Ehponline.org.  13 July 2011. 
Carlson-Lynch, H., Beck, B.D., and Boardman, P.D.  1994.  Arsenic Risk Assessment.  Review and 
Commentaries.  Environ Health Perspect 102(4): 354-356. 
ERG (Eastern Research Group, Inc.).  1997.  Report of the Expert Panel on Arsenic Carcinogenicity; Review 
and Workshop.  NCEA.  USEPA 665R97001.  August 1997. 
FDEP (Florida Department of Environmental Protection).  2005.  Technical Report: Development of Cleanup 
Target Levels (CTLs) for Chapter 62-777, F.A.C.  February 2005. 
Freeman, G.B., Johnson, J.D., Killinger, J.M., Liao, S.C., Davis, A.O., Ruby, M.V., Chaney, R.L., Lovre, 
S.C., and Bergstrom, P.D.  1993.  Bioavailability of Arsenic in Soil Impacted by Smelter Activities 
Following Oral Administration in Rabbits.  Fundam Appl Toxicol 21(1): 83-88. 
 
Proceedings of the Annual International Conference on Soils, Sediments, Water and Energy, Vol. 17 [2012], Art. 11
https://scholarworks.umass.edu/soilsproceedings/vol17/iss1/11




Freeman, G.B., Schoof, R.A., Ruby M.V., Davis, A.O., Dill, J.A., Liao, S.C., Lapin, C.A., and Bergstrom, 
P.D.  1995.  Bioavailability of Arsenic in Soil and House Dust Impacted by Smelter Activities 
Following Oral Administration in Cynomolgus Monkeys.  Fundam Appl Toxicol 28(2): 215-222. 
Gebel, T.W., Suchenwirth, R.H., Bolten, C., and Dunkelberg, H.H.  1998.  Human Biomonitoring of Arsenic 
and Antimony in Case of an Elevated Geogenic Exposure.  Environ Health Perspect 106(1): 33-39. 
Hinwood, A.L., Jolley, D.J., and Sim, M.R.  1999.  Cancer Incidence and High Environmental Arsenic 
Concentrations in Rural Populations: Results of an Ecological Study.  Int J Environ Health Res 9: 131-
141. 
Hughes, M.F., Beck, B.D., Chen, Y., Lewis, A.S., and Thomas, D.J.  2011.  Arsenic Exposure and 
Toxicology: A Historical Perspective.  Toxicol Sci 123(2): 305-332. 
Lamm, S.H., Engel, A., Kruse, M.B., Feinleib, M., Byrd, D.M., Lai, S., and Wilson, R.  2004.  Arsenic in 
Drinking Water and Bladder Cancer Mortality in the United States: An Analysis based on 133 U.S. 
Counties and 30 Years of Observation.  J Occup Environ Med 46(3): 298-306. 
NCI (National Cancer Institute).  2010.  U.S. Department of Health and Human Services – National Cancer 
Institute.  Cancer Incidence – Surveillance, Epidemiology, End Results (SEER) Registration Research 
Data.  November 2010. 
NRC (National Research Council).  1999.  Arsenic in Drinking Water.  National Academy Press.  
Washington, DC. 
Roberts, S. M., Weimar, W.R., Vinson, J.R.T., Munson, J.W., and Bergeron, R.J.  2002.  Measurement of 
Arsenic Bioavailability in Soil Using a Primate Model.  Toxicol Sci 67: 303-310. 
Rudel, R., Slayton, T.M., and Beck, B.D.  1996.  Implication of Arsenic Genotoxicity for Dose Response of 
Carcinogenic Effects.  Reg Toxicol Pharmacol 23: 87-105. 
Steinmaus, C., Moore, L., Hopenhayn-Rich, C., Biggs, M.L., and Smith, A.H.  2000.  Arsenic in Drinking 
Water and Bladder Cancer.  Canc Investig 18(2): 174-182. 
Thomas, D.J., Styblo, M., and Lin, S.  2001.  The Cellular Metabolism and Systemic Toxicity of Arsenic.  
Toxicol Appl Pharmacol 176: 127-144. 
Thomas, D.J., Li, J., Waters, S.B., Xing, W., Adair, B.M., Drobna, Z., Devesa, V., and Styblo, M.  2007.  
Arsenic (+3 Oxidation State) Methyltransferase and the Methylation of Arsenicals.  Exp Biol Med 
(Maywood) 232(1): 3-13. 
USEPA (United States Environmental Protection Agency).  2011a.  Regional Screening Level (RSL) 
Summary Table.  June 2011. 
USEPA (United States Environmental Protection Agency).  2011b.  IRIS (Integrated Risk Information 
System) online computer database.  
Vosnakis, K.A.S., Perry, E., Madsen, K., and Bradley, L.J.N.  2009.  Background versus Risk-Based 
Screening Levels – An Examination of Arsenic Background Soil Concentrations in Seven States.  
Proceedings of the Annual International Conference on Soils, Sediment, Water and Energy.  Vol 14 
Article 10.  
 
Teaf and Covert: Risk Considerations Related To Environmental Arsenic Exposure
Produced by The Berkeley Electronic Press, 2012
